Reithmeier T, Lopez W O, Doostkam S, Machein M R, Pinsker M O, Trippel M, Nikkhah G
Division of Stereotactic and Functional Neurosurgery, Department of General Neurosurgery, University Freiburg - Medical Center, Breisacher Straße 64, 79106 Freiburg, Germany.
Clin Neurol Neurosurg. 2013 Oct;115(10):1955-60. doi: 10.1016/j.clineuro.2013.05.019. Epub 2013 Jun 14.
There are concerns in the literature about the accuracy of histopathological diagnosis obtained by stereotactic biopsy in patients with brain tumours. The aim of this study was to analyse intraindividually the histopathological accuracy of stereotactic biopsies of intracerebral lesions in comparison to open surgical resection.
Between 2007 and 2011 a total of 635 patients underwent stereotactic serial biopsy in our department. Among these patients we identified 51 patients, who underwent magnetic resonance (MR) based stereotactic biopsy and subsequent open resection within 30 days. Mortality and morbidity data as well as final histopathological diagnoses of both procedures were compared with regard to tumour grade and tumour cell type. Patients with discrepancies between the histological diagnosis obtained by biopsy and open resection were classified into three subgroups (same cell type but different grading; same grading but different cell type and different grading as well as different cell type).
The mean number of tissue samples taken by stereotactic serial biopsy from each patient was 12 (range 7-21). Minor morbidity was 6% and major morbidity was 14% after open surgery compared to no morbidity after stereotactic biopsy. Mortality was 2% after stereotactic biopsy (one patient died after stereotactic biopsy as a result of a fatal bleeding) compared to 0% in the resection group. Silent bleeding rate without any clinical symptoms was 8% in the biopsy group. A complete correlation of histopathological findings between the biopsy group and the resection group was achieved in 76% and was increased to 90% by analyzing clinical and neuroradiological information. In patients with recurrence the correlation was higher (94%) than for patients with primary brain lesions (67%). The discrepancies between the open resection group and biopsy group were analysed.
Stereotactic MR guided serial biopsy is a minimal invasive procedure with low morbidity and high diagnostic accuracy for diagnosis and grading of brain tumours. Diagnostic accuracy of stereotactic biopsy can be enhanced further by careful interpretation of neuroradiological and clinical information.
文献中对脑肿瘤患者立体定向活检获得的组织病理学诊断准确性存在担忧。本研究的目的是与开放手术切除相比,个体内分析脑内病变立体定向活检的组织病理学准确性。
2007年至2011年期间,共有635例患者在我科接受了立体定向系列活检。在这些患者中,我们确定了51例在30天内接受基于磁共振(MR)的立体定向活检及随后开放切除的患者。比较了两种手术的死亡率和发病率数据以及最终组织病理学诊断的肿瘤分级和肿瘤细胞类型。活检与开放切除获得的组织学诊断存在差异的患者被分为三个亚组(细胞类型相同但分级不同;分级相同但细胞类型不同;分级和细胞类型均不同)。
立体定向系列活检从每位患者获取的组织样本平均数量为12个(范围7 - 21个)。与立体定向活检后无发病率相比,开放手术后轻微发病率为6%,严重发病率为14%。立体定向活检后死亡率为2%(1例患者因致命性出血在立体定向活检后死亡),而切除组为0%。活检组无任何临床症状的无症状出血率为8%。活检组与切除组的组织病理学结果完全相符率为76%,通过分析临床和神经放射学信息后升至90%。复发患者的相符率(94%)高于原发性脑病变患者(67%)。分析了开放切除组与活检组之间的差异。
立体定向MR引导下的系列活检是一种微创方法,对脑肿瘤的诊断和分级具有低发病率和高诊断准确性。通过仔细解读神经放射学和临床信息可进一步提高立体定向活检的诊断准确性。